A panel of experts gathered by the Food and Drug Administration on Tuesday narrowly endorsed drugmaker Merck’s COVID-19 antiviral pill, moving the drug a step closer to becoming the first pill authorized by the agency to treat the coronavirus.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
